Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression.

ABSTRACT:

SUBMITTER: Tantawy SI 

PROVIDER: S-EPMC12559276 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature